Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 5/2011

01.10.2011 | Clinical Investigation

Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up

verfasst von: Jean Palussière, Benjamin Marcet, Edouard Descat, Frédéric Deschamps, Pramod Rao, Alain Ravaud, Véronique Brouste, Thierry de Baère

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe the morphologic evolution of lung tumors treated with radiofrequency ablation (RFA) by way of computed tomography (CT) images and to investigate patterns of incomplete RFA at the site of ablation.

Materials and Methods

One hundred eighty-nine patients with 350 lung tumors treated with RFA underwent CT imaging at 2, 4, 6, and 12 months. CT findings were interpreted separately by two reviewers with consensus. Five different radiologic patterns were predefined: fibrosis, cavitation, nodule, atelectasis, and disappearance. The appearance of the treated area was evaluated at each follow-up CT using the predefined patterns.

Results

At 1 year after treatment, the most common evolutions were fibrosis (50.5%) or nodules (44.8%). Differences were noted depending on the initial size of the tumor, with fibrosis occurring more frequently for tumors <2 cm (58.6% vs. 22.9%, P = 1 × 10−5). Cavitation and atelectasis were less frequent patterns (2.4% and 1.4%, respectively, at 1 year). Tumor location (intraparenchymatous, with pleural contact <50% or >50%) was not significantly correlated with follow-up image pattern. Local tumor progressions were observed with each type of evolution. At 1 year, 12 local recurrences were noted: 2 cavitations, which represented 40% of the cavitations noted at 1 year; 2 fibroses (1.9%); 7 nodules (7.4%); and 1 atelectasis (33.3%).

Conclusion

After RFA of lung tumors, follow-up CT scans show that the shape of the treatment zone can evolve in five different patterns. None of these patterns, however, can confirm the absence of further local tumor progression at subsequent follow-up.
Literatur
1.
Zurück zum Zitat Abbas G, Schuchert MJ, Pennathur A et al (2007) Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin 17:261–271PubMedCrossRef Abbas G, Schuchert MJ, Pennathur A et al (2007) Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin 17:261–271PubMedCrossRef
2.
Zurück zum Zitat Dupuy DE, Mayo-Smith WW, Abbott GF et al (2002) Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 22(Spec No.):S259–S269PubMed Dupuy DE, Mayo-Smith WW, Abbott GF et al (2002) Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 22(Spec No.):S259–S269PubMed
3.
Zurück zum Zitat Rose SC, Thistlethwaite PA, Sewell PE et al (2006) Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 17:927–951PubMedCrossRef Rose SC, Thistlethwaite PA, Sewell PE et al (2006) Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 17:927–951PubMedCrossRef
4.
Zurück zum Zitat de Baère T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean followup of more than 1 year. AJR Am J Roentgenol 175:1619–1625PubMed de Baère T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean followup of more than 1 year. AJR Am J Roentgenol 175:1619–1625PubMed
5.
Zurück zum Zitat Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240PubMedCrossRef Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240PubMedCrossRef
6.
Zurück zum Zitat McGrane S, McSweeney SE, Maher MM (2008) Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging 33:48–53PubMedCrossRef McGrane S, McSweeney SE, Maher MM (2008) Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging 33:48–53PubMedCrossRef
7.
Zurück zum Zitat Suppiah A, White TJ, Roy-Choudhury SH et al (2007) Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes. Dig Surg 24:358–360PubMedCrossRef Suppiah A, White TJ, Roy-Choudhury SH et al (2007) Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes. Dig Surg 24:358–360PubMedCrossRef
8.
Zurück zum Zitat Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities. Part II. J Vasc Interv Radiol 12:1135–1148PubMedCrossRef Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities. Part II. J Vasc Interv Radiol 12:1135–1148PubMedCrossRef
9.
Zurück zum Zitat Zagoria RJ, Traver MA, Werle DM et al (2007) Oncologic efficacy of computed tomography (CT)-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429–436PubMedCrossRef Zagoria RJ, Traver MA, Werle DM et al (2007) Oncologic efficacy of computed tomography (CT)-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429–436PubMedCrossRef
10.
Zurück zum Zitat Park S, Cadeddu JA (2007) Outcomes of radiofrequency ablation for kidney cancer. Cancer Control 14:205–210PubMed Park S, Cadeddu JA (2007) Outcomes of radiofrequency ablation for kidney cancer. Cancer Control 14:205–210PubMed
11.
Zurück zum Zitat Link TM, de Mayo R, O’Donnell RJ (2007) Radiofrequency ablation: an alternative for definitive treatment of solitary bone metastases. Eur Radiol 17:3012–3013PubMedCrossRef Link TM, de Mayo R, O’Donnell RJ (2007) Radiofrequency ablation: an alternative for definitive treatment of solitary bone metastases. Eur Radiol 17:3012–3013PubMedCrossRef
12.
Zurück zum Zitat Suh R, Reckamp K, Zeidler M et al (2005) Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park) 19(11 Suppl 4):12–21 Suh R, Reckamp K, Zeidler M et al (2005) Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park) 19(11 Suppl 4):12–21
13.
Zurück zum Zitat Simon CJ, Dupuy DE, DiPetrillo TA et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268–275PubMedCrossRef Simon CJ, Dupuy DE, DiPetrillo TA et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268–275PubMedCrossRef
14.
Zurück zum Zitat Yan TD, King J, Sjarif A et al (2006) Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13:1529–1537PubMedCrossRef Yan TD, King J, Sjarif A et al (2006) Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13:1529–1537PubMedCrossRef
15.
Zurück zum Zitat Yan TD, King J, Sjarif A et al (2007) Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 14:1718–1726PubMedCrossRef Yan TD, King J, Sjarif A et al (2007) Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 14:1718–1726PubMedCrossRef
16.
Zurück zum Zitat de Baère T, Palussière J, Auperin A et al (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587–596PubMedCrossRef de Baère T, Palussière J, Auperin A et al (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587–596PubMedCrossRef
17.
Zurück zum Zitat Therasse P (2002) Evaluation of response: new and standard criteria. Ann Oncol 13(Suppl 4):127–129PubMedCrossRef Therasse P (2002) Evaluation of response: new and standard criteria. Ann Oncol 13(Suppl 4):127–129PubMedCrossRef
18.
Zurück zum Zitat Shuster JJ (1991) Median follow-up in clinical trials. J Clin Oncol 9:191–192PubMed Shuster JJ (1991) Median follow-up in clinical trials. J Clin Oncol 9:191–192PubMed
19.
Zurück zum Zitat Ahmed M, Liu Z, Afzal KS et al (2004) Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 230:761–767PubMedCrossRef Ahmed M, Liu Z, Afzal KS et al (2004) Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 230:761–767PubMedCrossRef
20.
Zurück zum Zitat Goldberg SN, Gazelle GS, Compton CC et al (1995) Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 2:776–784PubMedCrossRef Goldberg SN, Gazelle GS, Compton CC et al (1995) Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 2:776–784PubMedCrossRef
21.
Zurück zum Zitat Yamamoto A, Nakamura K, Matsuoka T et al (2005) Radiofrequency ablation in a porcine lung model: correlation between computed tomography (CT) and histopathologic findings. AJR Am J Roentgenol 185:1299–1306PubMedCrossRef Yamamoto A, Nakamura K, Matsuoka T et al (2005) Radiofrequency ablation in a porcine lung model: correlation between computed tomography (CT) and histopathologic findings. AJR Am J Roentgenol 185:1299–1306PubMedCrossRef
22.
Zurück zum Zitat Suh RD, Wallace AB, Sheehan RE et al (2003) Unresectable pulmonary malignancies: computed tomography (CT)-guided percutaneous radiofrequency ablation: preliminary results. Radiology 229:821–829PubMedCrossRef Suh RD, Wallace AB, Sheehan RE et al (2003) Unresectable pulmonary malignancies: computed tomography (CT)-guided percutaneous radiofrequency ablation: preliminary results. Radiology 229:821–829PubMedCrossRef
23.
Zurück zum Zitat Steinke K, Glenn D, King J et al (2004) Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 11:207–212PubMedCrossRef Steinke K, Glenn D, King J et al (2004) Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 11:207–212PubMedCrossRef
24.
Zurück zum Zitat Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) computed tomography (CT) imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: Results in 32 tumors. AJR Am J Roentgenol 185:466–471PubMed Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) computed tomography (CT) imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: Results in 32 tumors. AJR Am J Roentgenol 185:466–471PubMed
25.
Zurück zum Zitat Lee JM, Jin GY, Goldberg SN et al (2004) Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230:125–134PubMedCrossRef Lee JM, Jin GY, Goldberg SN et al (2004) Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230:125–134PubMedCrossRef
26.
Zurück zum Zitat Anderson EM, Lees WR, Gillams AR (2009) Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 32:478–483PubMedCrossRef Anderson EM, Lees WR, Gillams AR (2009) Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 32:478–483PubMedCrossRef
27.
Zurück zum Zitat Brace CL, Diaz TA, Hinshaw JL et al (2010) Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Interv Radiol 21:1280–1286PubMedCrossRef Brace CL, Diaz TA, Hinshaw JL et al (2010) Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Interv Radiol 21:1280–1286PubMedCrossRef
28.
Zurück zum Zitat Hakimé A, Peddi H, Hines-Peralta AU et al (2007) computed tomography (CT) perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology 243:712–719PubMedCrossRef Hakimé A, Peddi H, Hines-Peralta AU et al (2007) computed tomography (CT) perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology 243:712–719PubMedCrossRef
29.
Zurück zum Zitat Schaefer JF, Vollmar J, Schick F et al (2004) Solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging–perfusion differences in malignant and benign lesions. Radiology 232:544–553PubMedCrossRef Schaefer JF, Vollmar J, Schick F et al (2004) Solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging–perfusion differences in malignant and benign lesions. Radiology 232:544–553PubMedCrossRef
30.
Zurück zum Zitat VanSonnenberg E, Shankar S, Morrison PR et al (2005) Radiofrequency ablation of thoracic lesions. Part 2. Initial clinical experience: technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 184:381–390PubMed VanSonnenberg E, Shankar S, Morrison PR et al (2005) Radiofrequency ablation of thoracic lesions. Part 2. Initial clinical experience: technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 184:381–390PubMed
31.
Zurück zum Zitat Okuma T, Matsuoka T, Yamamoto A et al (2009) Assessment of early treatment response after computed tomography (CT)-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study. Br J Radiol 82:989–994PubMedCrossRef Okuma T, Matsuoka T, Yamamoto A et al (2009) Assessment of early treatment response after computed tomography (CT)-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study. Br J Radiol 82:989–994PubMedCrossRef
32.
Zurück zum Zitat Okuma T, Matsuoka T, Okamura T et al (2006) 18F-FDG small-animal PET for monitoring the therapeutic effect of computed tomography (CT)-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351–1358PubMed Okuma T, Matsuoka T, Okamura T et al (2006) 18F-FDG small-animal PET for monitoring the therapeutic effect of computed tomography (CT)-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351–1358PubMed
33.
Zurück zum Zitat Okuma T, Okamura T, Matsuoka T et al (2006) Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after computed tomography (CT)-guided radiofrequency ablation: preliminary results. Ann Nucl Med 20:115–121PubMedCrossRef Okuma T, Okamura T, Matsuoka T et al (2006) Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after computed tomography (CT)-guided radiofrequency ablation: preliminary results. Ann Nucl Med 20:115–121PubMedCrossRef
34.
Zurück zum Zitat Avril N (2006) 18F-FDG PET after radiofrequency ablation: Is timing everything? J Nucl Med 47:1235–1237PubMed Avril N (2006) 18F-FDG PET after radiofrequency ablation: Is timing everything? J Nucl Med 47:1235–1237PubMed
35.
Zurück zum Zitat Hataji O, Yamakado K, Nakatsuka A et al (2005) Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation. Intern Med 44:865–869PubMedCrossRef Hataji O, Yamakado K, Nakatsuka A et al (2005) Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation. Intern Med 44:865–869PubMedCrossRef
36.
Zurück zum Zitat Okuma T, Matsuoka T, Yamamoto A et al (2007) Factors contributing to cavitation after computed tomography (CT)-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol 18:399–404PubMedCrossRef Okuma T, Matsuoka T, Yamamoto A et al (2007) Factors contributing to cavitation after computed tomography (CT)-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol 18:399–404PubMedCrossRef
Metadaten
Titel
Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up
verfasst von
Jean Palussière
Benjamin Marcet
Edouard Descat
Frédéric Deschamps
Pramod Rao
Alain Ravaud
Véronique Brouste
Thierry de Baère
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 5/2011
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-010-0048-z

Weitere Artikel der Ausgabe 5/2011

CardioVascular and Interventional Radiology 5/2011 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.